Gross Profit Summary of BioVaxys Technology Corp.

BioVaxys Technology Corp.'s latest annual gross profit in 2023 was - CAD , down 0.0% from previous year.
BioVaxys Technology Corp.'s latest quarterly gross profit in 2024 Q3 was - CAD , down 0.0% from previous quarter.
BioVaxys Technology Corp. reported a annual gross profit of - CAD in annual gross profit 2022, down 0.0% from previous year.
BioVaxys Technology Corp. reported a annual gross profit of - CAD in annual gross profit 2021, down 0.0% from previous year.
BioVaxys Technology Corp. reported a quarterly gross profit of - CAD for 2024 Q3, down 0.0% from previous quarter.
BioVaxys Technology Corp. reported a quarterly gross profit of - CAD for 2024 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of BioVaxys Technology Corp. (2023 - 2019)

Name	Gross Profit	Gross Profit Difference
Algernon Pharmaceuticals Inc.	-50.39 Thousand CAD	100.0%
Asep Medical Holdings Inc	-113.74 Thousand CAD	100.0%
BetterLife Pharma Inc.	- CAD	NaN%
ChitogenX Inc.	-42 Thousand CAD	100.0%
Rapid Dose Therapeutics Corp.	563.4 Thousand CAD	100.0%
Defence Therapeutics Inc.	-90.92 Thousand CAD	100.0%
Entheon Biomedical Corp.	250.32 Thousand CAD	100.0%
Gemina Laboratories Ltd.	-93.36 Thousand CAD	100.0%
Glow Lifetech Corp.	-505.62 Thousand CAD	100.0%
Lexston Life Sciences Corp.	-26.39 Thousand CAD	100.0%
Pharmala Biotech Holdings Inc.	454.09 Thousand CAD	100.0%
Doseology Sciences Inc.	-36.08 Thousand CAD	100.0%
MYND Life Sciences Inc.	-332.99 Thousand CAD	100.0%
Nova Mentis Life Science Corp.	25.4 Thousand CAD	100.0%
PharmaTher Holdings Ltd.	-711.00 CAD	100.0%
PreveCeutical Medical Inc.	-9856.00 CAD	100.0%
Telescope Innovations Corp.	595.39 Thousand CAD	100.0%